J. Gehret

Suppression of Lethal Ischemic Ventricular Arrhythmias by the Class III Agent E4031 in a Canine Model of Previous Myocardial Infarction

H. Selnick, R. Stein, J. Lynch, 1990, Journal of cardiovascular pharmacology.

Cardiac electrophysiologic and antiarrhythmic actions of tedisamil.

J. Lynch, E. Baskin, S. D. Appleby, 1995, The Journal of pharmacology and experimental therapeutics.

Arrhythmogenic potential of positive inotropic agents

G. Stump, A. Wallace, J. Gehret, 2000, Basic Research in Cardiology.

Differential efficacy of the class III agent MK-499 against programmed stimulation-induced and ischemic-induced ventricular arrhythmias in a canine model of previous myocardial infarction.

J. Lynch, G. Stump, A. Wallace, 1996, The Journal of pharmacology and experimental therapeutics.

Antiarrhythmic actions of tocainide in canine models of previous myocardial infarction.

J. Lynch, L. Heaney, A. Wallace, 1991, American heart journal.

Nonpeptide glycoprotein IIb/IIIa inhibitors. 8. Antiplatelet activity and oral antithrombotic efficacy of L-734,217.

R. Gould, G. Hartman, N. Ihle, 1996, The Journal of pharmacology and experimental therapeutics.

An alternative method of chronic cerebrospinal fluid collection via the cisterna magna in conscious rhesus monkeys.

S. Motzel, J. Cook, M. Holahan, 2003, Contemporary topics in laboratory animal science.

Failure of Lidocaine to Suppress Lethal Ischemic Ventricular Arrhythmias in a Canine Model of Previous Myocardial Infarction

J. Lynch, R. Stein, A. Wallace, 1990, Journal of cardiovascular pharmacology.

Chronic catheterization of the intestines and portal vein for absorption experimentation in beagle dogs.

G. Kwei, L. Novak, J. Gehret, 1995, Laboratory animal science.